1. Males
N=887
73%
Females
N=334
27%
Total
1221
100%
New Jersey Basic Life Support Emergency Medical Services
Naloxone Analysis
Evan Gross, Intern
Dr. Terry Clancy, Preceptor
New Jersey Department of Health, OEMS
72%
20%
8%
Statewide Patient Responses to Naloxone
Administration
• Patient response
72%, n=878; (i.e.,
alert, oriented,
confused, vomiting,
combative)
• No patient response
(20%, n=241)
• Unknown or other
(8%, n=102)
• To analyze the Naloxone (Narcan®) Basic
Life Support (BLS) program data for New
Jersey and make policy recommendations
to improve pre-hospital response to opioid
overdoses.
Photo obtained from http://bit.ly/1eSxqf8
• Opioid abuse has increased nationally and
in New Jersey over the past two decades.
• Overdose Prevention Act authorized
Emergency Medical Technicians (EMTs) to
administer Naloxone.
• Naloxone administration data in New Jersey
has been collected, not analyzed thus far.
Purpose
• A special thank you to Dr. Terry Clancy,
Internship Preceptor, Ann Marie Hill,
Internship Coordinator, and the Office of
Emergency Medical Services staff for their
guidance.
• Variables identified can be further analyzed
to identify gaps in Naloxone administration,
MAR reporting, and treatment strategies.
• Analysis provides OEMS with target
populations to enhance treatment and
prevention initiatives to improve the public
health response to the opioid epidemic.
Evaluation
Acknowledgements
Significance
Method/Approach
1,221 MARs remained
Analyzed to evaluate trends in Naloxone
administration
152 MARs removed - do not fit criteria
(i.e., practice MARs, unregistered police & fire
agencies, & administrations that deviated
from protocol)
Retrospective review of 1,373 NJ BLS Naloxone
Medication Administration Reports (MARs)
(April 2014-December 2015)
398
129 128
0
50
100
150
200
250
300
350
400
450
#1 Camden #2 Ocean #3 Hudson
#ofAdministrations
County
NJ counties with greatest # of
administrations
Apr 2014 – Dec 2015
Statewide age groups with greatest
# of Naloxone administrations
#1: 20-29 years of age
453 (37.1% of administrations)
#2: 30-39 years of age
330 (27.0% of administrations)
#3: 40-49 years of age
205 (16.8% of administrations)
Outcomes